Science policy news weekly roundup: June 19, 2015 ?>

Science policy news weekly roundup: June 19, 2015

The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to for inclusion in next week’s roundup.

Stay tuned to the Policy Blotter next week as we discuss reproducibility in research and explore just exactly what is going on with the fiscal 2016 budgeting process.

Office of Extramural Research

NIH extramural research chief steps down (Science Insider) Office of Extramural Research Director, Sally Rockey, steps down.

House Appropriations Bill

Appropriations Bill Favors NIH (ASBMB Policy Blotter) U.S. House of Representatives Labor, Health, Human Services and Education Related Agencies subcommittee released an appropriations bill which would increase funding for the NIH and CDC, but cut funding to other public health services.

Appropriations Committee Releases the Fiscal Year 2016 Labor, Health and Human Services Funding Bill (

NIH boost masks GOP cuts elsewhere from Obama’s budget (Politico)

CDC, NIH win big in healthcare spending bill (The Hill)

House bill would give NIH $1.1 billion more in 2016 (Science Insider)

GOP unveils spending bill that targets ObamaCare (The Hill)

21st Century Cures Act

New Legislation In Congress Could Help Restore America To Scientific Excellence (Forbes)

DeGette and Upton: New cures for the 21st century (The Denver Post) U.S. Reps. Diana DeGette, D-Colo, and Fred Upton, R-Mich, provide their perspective on 21st Century Cures legislation.

Another Voice: Treatment of rare diseases must be improved (The Buffalo News) U.S. Rep. Chris Collins explains how 21st Century Cures could expedite treatment delivery for rare diseases.

Industry and Academia Relationship

Biotechnology and pharmaceutical industry benefit from basic research funding; both sectors weigh in on importance of funding NIH.

New Research Shows Growing Industry-Academic Ties in Advancing New Medicines to Improve Patient Lives (Business Wire)

Biotech leaders cite threats to industry’s funding model (The Boston Globe) Biotechnology industry depends on NIH funded, academic research to deliver medical devices.

Academia Is Pivotal To The Future Of Pharma Innovation (Pharmaceutical Online) Pharmaceutical industry also depends on NIH funded, academic research to bring new drugs to patients.

Additional Articles of Interest:

Science Interrupted: How Young Investigators Must Sideline Science to Compete for Scarce Funding (UCSF)

Planning for US Precision Medicine Initiative underway (The Lancet)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.